Prestige Consumer Healthcare (PBH) Invested Capital (2013 - 2025)

Prestige Consumer Healthcare's Invested Capital history runs 10 years deep, the most recent figure standing at $21.3 million for Q4 2025.

• On a quarterly basis, Invested Capital rose 327.29% year-over-year to $21.3 million in Q4 2025; TTM through Dec 2025 was $88.8 million, a 1037.58% increase from a year earlier, with the FY2025 full-year figure at $23.1 million, up 1287.39% from the prior year.
• Invested Capital eased to $21.3 million in Q4 2025 per PBH's latest filing, from $21.9 million in the prior quarter.
• Across five years, Invested Capital topped out at $23.1 million in Q1 2025 and bottomed at $217000.0 in Q3 2024.
• The 5-year median for Invested Capital is $6.2 million (2022), against an average of $8.5 million.
• Across the five-year window, Invested Capital tumbled 92.99% in 2024 and surged 9988.02% in 2025, its largest moves.
• Year by year, Invested Capital stood at $7.5 million in 2021, then slumped by 30.44% to $5.2 million in 2022, then slumped by 54.15% to $2.4 million in 2023, then jumped by 108.85% to $5.0 million in 2024, then surged by 327.29% to $21.3 million in 2025.
• Per Business Quant, the three latest PBH Invested Capital figures stand at $21.3 million (Q4 2025), $21.9 million (Q3 2025), and $22.5 million (Q2 2025).